ENP20: Burosumab

We look into promising findings from clinical trials regarding Burosumab, a human monoclonal antibody designed for the treatment of X-linked hypophosphatemia. With us are Erik Imel, MD from the Indiana University School of Medicine and Suzanne Marie Jan De Beur, MD from Johns Hopkins University School of Medicine. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Episode metadata supplied by the publisher feed · Published May 29, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

ENP20: Burosumab

0:00 18:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Endocrine News Podcast?

This episode is 18 minutes long.

When was this Endocrine News Podcast episode published?

This episode was published on May 29, 2019.

Can I download this Endocrine News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!